Works matching Naltrexone
Results: 3295
Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2017, v. 95, n. 1, p. 16, doi. 10.1139/cjpp-2016-0188
- By:
- Publication type:
- Article
Differential effects of naltrexone on cardiac, subjective and behavioural reactions to acute ethanol intoxication.
- Published in:
- Journal of Psychiatry & Neuroscience, 2006, v. 31, n. 6, p. 386
- By:
- Publication type:
- Article
Zastosowanie naltreksonu w terapii uzależnienia od alkoholu -- aspekty farmakologiczne.
- Published in:
- Psychiatria Polska, 2013, v. 47, n. 1, p. 117
- By:
- Publication type:
- Article
Comparison of oral naltrexone and naltrexone implant treatment in alcohol use disorders.
- Published in:
- Anatolian Journal of Psychiatry / Anadolu Psikiyatri Dergisi, 2020, v. 21, n. 5, p. 477, doi. 10.5455/apd.77447
- By:
- Publication type:
- Article
Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
- Published in:
- Addiction, 2004, v. 99, n. 7, p. 811, doi. 10.1111/j.1360-0443.2004.00763.x
- By:
- Publication type:
- Article
Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking Naltrexone effects on alcohol consumption: temporal effects.
- Published in:
- Psychopharmacology, 2004, v. 173, n. 1/2, p. 32, doi. 10.1007/s00213-003-1720-7
- By:
- Publication type:
- Article
The Safety and Efficacy of Low‐Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 3, p. 382, doi. 10.1002/phar.2086
- By:
- Publication type:
- Article
Efficacy and Safety of Low Dose Naltrexone for Chronic Pain.
- Published in:
- Journal of Pain & Palliative Care Pharmacotherapy, 2024, v. 38, n. 1, p. 13, doi. 10.1080/15360288.2024.2302550
- By:
- Publication type:
- Article
Extended-release morphine sulfate and naltrexone hydrochloride (EMBEDA): naltrexone-associated withdrawal and abuse-related effects in patients with chronic pain and recreational opioid users.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization.
- Published in:
- Medical Sciences, 2018, v. 6, n. 4, p. 82, doi. 10.3390/medsci6040082
- By:
- Publication type:
- Article
Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone.
- Published in:
- Substance Abuse: Research & Treatment, 2013, n. 7, p. 75, doi. 10.4137/SART.S10776
- By:
- Publication type:
- Article
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.
- Published in:
- Addiction, 2017, v. 112, n. 6, p. 1036, doi. 10.1111/add.13753
- By:
- Publication type:
- Article
Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial.
- Published in:
- Addiction, 2015, v. 110, n. 6, p. 1008, doi. 10.1111/add.12894
- By:
- Publication type:
- Article
Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.
- Published in:
- Addiction, 2011, v. 106, n. 7, p. 1309, doi. 10.1111/j.1360-0443.2011.03400.x
- By:
- Publication type:
- Article
A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.
- Published in:
- Alcohol & Alcoholism, 2020, v. 55, n. 1, p. 56, doi. 10.1093/alcalc/agz076
- By:
- Publication type:
- Article
Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 370, doi. 10.1002/cpdd.177
- By:
- Publication type:
- Article
Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended-release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended-release oxycodone with sequestered naltrexone 80 mg once daily
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 361, doi. 10.1002/cpdd.179
- By:
- Publication type:
- Article
The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review.
- Published in:
- Journal of Pain Research, 2023, v. 16, p. 1017, doi. 10.2147/JPR.S395457
- By:
- Publication type:
- Article
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Favorable Mortality Profile of Naltrexone Implants for Opiate Addiction.
- Published in:
- Journal of Addictive Diseases, 2010, v. 29, n. 1, p. 30, doi. 10.1080/10550880903435988
- By:
- Publication type:
- Article
Evaluating the antagonist effect of naltrexone implant via opioid challenge tests with escalating doses of hydromorphone injection in former heroin dependent patients.
- Published in:
- Frontiers in Psychiatry, 2025, p. 1, doi. 10.3389/fpsyt.2025.1441598
- By:
- Publication type:
- Article
Improving clinical outcomes for naltrexone as a management of problem alcohol use.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 5, p. 632, doi. 10.1111/j.1365-2125.2012.04452.x
- By:
- Publication type:
- Article
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1240, doi. 10.3390/cancers16061240
- By:
- Publication type:
- Article
Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases.
- Published in:
- Integrative Cancer Therapies, 2009, v. 8, n. 4, p. 416, doi. 10.1177/1534735409352082
- By:
- Publication type:
- Article
Naltrexone and Its Noroxymorphone Minor Metabolite - A Case Report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An unusual reaction to opioid blockade with naltrexone in a case of post-traumatic stress disorder.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 6, p. 1, doi. 10.1002/hup.2800
- By:
- Publication type:
- Article
In vitro evaluation of Naltrexone HCl 1% Topical Cream in XemaTop™ for psoriasis.
- Published in:
- Archives of Dermatological Research, 2020, v. 312, n. 2, p. 145, doi. 10.1007/s00403-019-01981-2
- By:
- Publication type:
- Article
Influence of Microencapsulation Process Parameters on Naltrexone Prolonged-Release Dosage Form.
- Published in:
- Pharmaceutical Chemistry Journal, 2014, v. 48, n. 1, p. 65, doi. 10.1007/s11094-014-1048-0
- By:
- Publication type:
- Article
Differences in δ- and μ-Opioid Receptor Blockade Measured by Positron Emission Tomography in Naltrexone-Treated Recently Abstinent Alcohol-Dependent Subjects.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 3, p. 653, doi. 10.1038/sj.npp.1301440
- By:
- Publication type:
- Article
Gene Transcription Alterations Associated with Decrease of Ethanol Intake Induced by Naltrexone in the Brain of Wistar Rats.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 6, p. 1358, doi. 10.1038/sj.npp.1301237
- By:
- Publication type:
- Article
Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of Alcoholism.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 8, p. 1793, doi. 10.1038/sj.npp.1300994
- By:
- Publication type:
- Article
Vivitrex®, an Injectable, Extended-Release Formulation of Naltrexone, Provides Pharmacokinetic and Pharmacodynamic Evidence of Efficacy for I Month in Rats.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 11, p. 1973, doi. 10.1038/sj.npp.1300274
- By:
- Publication type:
- Article
A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 8, p. 1546, doi. 10.1038/sj.npp.1300219
- By:
- Publication type:
- Article
Effects of Naltrexone Alone and In Combination With Acamprosate on the Alcohol Deprivation Effect in Rats.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 8, p. 1463, doi. 10.1038/sj.npp.1300175
- By:
- Publication type:
- Article
A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone
- Published in:
- Neuropsychopharmacology, 2002, v. 27, n. 4, p. 596, doi. 10.1016/S0893-133X(02)00368-8
- By:
- Publication type:
- Article
Hypothalamic-Pituitary-Adrenocortical (HPA) Axis Response and Biotransformation of Oral Naltrexone: Preliminary Examination of Relationship to Family History of Alcoholism
- Published in:
- Neuropsychopharmacology, 2002, v. 26, n. 6, p. 778, doi. 10.1016/S0893-133X(01)00416-X
- By:
- Publication type:
- Article
Role of State Policies in the Adoption of Naltrexone for Substance Abuse Treatment.
- Published in:
- Health Services Research, 2008, v. 43, n. 3, p. 951, doi. 10.1111/j.1475-6773.2007.00812.x
- By:
- Publication type:
- Article
Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 10, p. 1495, doi. 10.3390/biom11101495
- By:
- Publication type:
- Article
Effects of Naltrexone on Large-Scale Network Interactions in Methamphetamine Use Disorder.
- Published in:
- Frontiers in Psychiatry, 2019, p. 1, doi. 10.3389/fpsyt.2019.00603
- By:
- Publication type:
- Article
FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2021, v. 271, n. 5, p. 915, doi. 10.1007/s00406-021-01259-7
- By:
- Publication type:
- Article
Successful treatment of dextromethorphan use disorder with combined naltrexone and gabapentin: a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid users.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.
- Published in:
- American Journal of Drug & Alcohol Abuse, 2015, v. 41, n. 1, p. 35, doi. 10.3109/00952990.2014.927881
- By:
- Publication type:
- Article
Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone.
- Published in:
- American Journal of Drug & Alcohol Abuse, 2014, v. 40, n. 2, p. 103, doi. 10.3109/00952990.2013.853074
- By:
- Publication type:
- Article
The association between naltrexone treatment and symptoms of depression in opioid-dependent patients.
- Published in:
- American Journal of Drug & Alcohol Abuse, 2011, v. 37, n. 1, p. 22, doi. 10.3109/00952990.2010.540281
- By:
- Publication type:
- Article
Patient and Provider Attitudes towards Monitored Naltrexone Treatment of Alcohol Dependence in Schizophrenia.
- Published in:
- American Journal of Drug & Alcohol Abuse, 2009, v. 35, n. 5, p. 273, doi. 10.1080/00952990902939727
- By:
- Publication type:
- Article